Compare Sempra Energy (SRE) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sempra Energy vs State Street SPDR S&P Biotech ETF — how do they compare? Sempra Energy trades at $81.34 (market cap $52.36B), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: Sempra Energy is far larger — about 5.2× State Street SPDR S&P Biotech ETF's market cap, and Sempra Energy pays a 3.28% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sempra Energy for 9 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| SRE | XBI | |
|---|---|---|
Market Cap | $52.36B | $10.11B |
Volume | 3,338,383 | 12,903,266 |
Sector | Utilities | Broad Market / Factor |
52-Week High | $99.75 | $169.55 |
52-Week Low | $76.90 | $104.99 |
Typical Hold Time | 9 Days | 38 Days |
Enterprise Value | $89.00B | — |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $149.29, down 0.63% on the day, with technical indicators showing a bearish bias despite oversold RSI conditions. The ETF faces mixed sentiment with 100% hold ratings from analysts but positive catalysts from biotech breakthroughs. Recent news highlights XBI's 76% rally over the past year and ongoing M&A activity driving sector optimism.
Outlook remains cautiously optimistic with potential upside from cancer vaccine developments and sector consolidation, though high volatility and expense ratios relative to broader healthcare ETFs present risks. The ETF's modified equal-weight structure offers diversified exposure to 150+ biotech names, benefiting from improved capital access and clinical trial catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sempra Energy
Sempra is an energy infrastructure company with regulated utility and energy network businesses. Its operations include electric and gas utilities as well as energy infrastructure in North America.
Read more on SRE →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
